Global Digital Therapeutics for Nervous System Diseases Market Growth (Status and Outlook) 2026-2032
The global Digital Therapeutics for Nervous System Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Digital Therapeutics for Nervous System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent nervous system diseases.
United States market for Digital Therapeutics for Nervous System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Digital Therapeutics for Nervous System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Digital Therapeutics for Nervous System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Digital Therapeutics for Nervous System Diseases players cover Zoecare, 66nao, MedRhythms, Curelator, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Digital Therapeutics for Nervous System Diseases Industry Forecast” looks at past sales and reviews total world Digital Therapeutics for Nervous System Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Digital Therapeutics for Nervous System Diseases sales for 2026 through 2032. With Digital Therapeutics for Nervous System Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Therapeutics for Nervous System Diseases industry.
This Insight Report provides a comprehensive analysis of the global Digital Therapeutics for Nervous System Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Therapeutics for Nervous System Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Therapeutics for Nervous System Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Therapeutics for Nervous System Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Therapeutics for Nervous System Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Therapeutics for Nervous System Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
Digital Therapeutics for Nervous System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent nervous system diseases.
United States market for Digital Therapeutics for Nervous System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Digital Therapeutics for Nervous System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Digital Therapeutics for Nervous System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Digital Therapeutics for Nervous System Diseases players cover Zoecare, 66nao, MedRhythms, Curelator, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Digital Therapeutics for Nervous System Diseases Industry Forecast” looks at past sales and reviews total world Digital Therapeutics for Nervous System Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Digital Therapeutics for Nervous System Diseases sales for 2026 through 2032. With Digital Therapeutics for Nervous System Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Therapeutics for Nervous System Diseases industry.
This Insight Report provides a comprehensive analysis of the global Digital Therapeutics for Nervous System Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Therapeutics for Nervous System Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Therapeutics for Nervous System Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Therapeutics for Nervous System Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Therapeutics for Nervous System Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Therapeutics for Nervous System Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prevention
- Management
- Treatment
- Epilepsy
- Parkinson's Disease
- Alzheimer's Disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoecare
- 66nao
- MedRhythms
- Curelator
- Sanofi
- GYENNO SCIENCE
- Cognito Therapeutics
- Nanjing Vishee Medical Technology Co.,Ltd.
- Glecan
- Xinkangyx
- WonderLab
- BestCovered, Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Digital Therapeutics for Nervous System Diseases Market Size (2021-2032)
2.1.2 Digital Therapeutics for Nervous System Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Digital Therapeutics for Nervous System Diseases by Country/Region (2021, 2025 & 2032)
2.2 Digital Therapeutics for Nervous System Diseases Segment by Type
2.2.1 Prevention
2.2.2 Management
2.2.3 Treatment
2.2.4 Digital Therapeutics for Nervous System Diseases Market Size by Type
2.2.4.1 Digital Therapeutics for Nervous System Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
2.3 Digital Therapeutics for Nervous System Diseases Segment by Application
2.3.1 Epilepsy
2.3.2 Parkinson's Disease
2.3.3 Alzheimer's Disease
2.3.4 Other
2.3.5 Digital Therapeutics for Nervous System Diseases Market Size by Application
2.3.5.1 Digital Therapeutics for Nervous System Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
3 DIGITAL THERAPEUTICS FOR NERVOUS SYSTEM DISEASES MARKET SIZE BY PLAYER
3.1 Digital Therapeutics for Nervous System Diseases Market Size Market Share by Player
3.1.1 Global Digital Therapeutics for Nervous System Diseases Revenue by Player (2021-2026)
3.1.2 Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Digital Therapeutics for Nervous System Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIGITAL THERAPEUTICS FOR NERVOUS SYSTEM DISEASES BY REGION
4.1 Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026)
4.2 Global Digital Therapeutics for Nervous System Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
4.4 APAC Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
4.5 Europe Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026)
5.2 Americas Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
5.3 Americas Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026)
6.2 APAC Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
6.3 APAC Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026)
7.2 Europe Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
7.3 Europe Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Digital Therapeutics for Nervous System Diseases by Region (2021-2026)
8.2 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIGITAL THERAPEUTICS FOR NERVOUS SYSTEM DISEASES MARKET FORECAST
10.1 Global Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.1.1 Global Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.1.2 Americas Digital Therapeutics for Nervous System Diseases Forecast
10.1.3 APAC Digital Therapeutics for Nervous System Diseases Forecast
10.1.4 Europe Digital Therapeutics for Nervous System Diseases Forecast
10.1.5 Middle East & Africa Digital Therapeutics for Nervous System Diseases Forecast
10.2 Americas Digital Therapeutics for Nervous System Diseases Forecast by Country (2027-2032)
10.2.1 United States Market Digital Therapeutics for Nervous System Diseases Forecast
10.2.2 Canada Market Digital Therapeutics for Nervous System Diseases Forecast
10.2.3 Mexico Market Digital Therapeutics for Nervous System Diseases Forecast
10.2.4 Brazil Market Digital Therapeutics for Nervous System Diseases Forecast
10.3 APAC Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.3.1 China Digital Therapeutics for Nervous System Diseases Market Forecast
10.3.2 Japan Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.3 Korea Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.4 Southeast Asia Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.5 India Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.6 Australia Market Digital Therapeutics for Nervous System Diseases Forecast
10.4 Europe Digital Therapeutics for Nervous System Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.2 France Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.3 UK Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.4 Italy Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.5 Russia Market Digital Therapeutics for Nervous System Diseases Forecast
10.5 Middle East & Africa Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market Digital Therapeutics for Nervous System Diseases Forecast
10.5.2 South Africa Market Digital Therapeutics for Nervous System Diseases Forecast
10.5.3 Israel Market Digital Therapeutics for Nervous System Diseases Forecast
10.5.4 Turkey Market Digital Therapeutics for Nervous System Diseases Forecast
10.6 Global Digital Therapeutics for Nervous System Diseases Forecast by Type (2027-2032)
10.7 Global Digital Therapeutics for Nervous System Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Digital Therapeutics for Nervous System Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 Zoecare
11.1.1 Zoecare Company Information
11.1.2 Zoecare Digital Therapeutics for Nervous System Diseases Product Offered
11.1.3 Zoecare Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Zoecare Main Business Overview
11.1.5 Zoecare Latest Developments
11.2 66nao
11.2.1 66nao Company Information
11.2.2 66nao Digital Therapeutics for Nervous System Diseases Product Offered
11.2.3 66nao Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 66nao Main Business Overview
11.2.5 66nao Latest Developments
11.3 MedRhythms
11.3.1 MedRhythms Company Information
11.3.2 MedRhythms Digital Therapeutics for Nervous System Diseases Product Offered
11.3.3 MedRhythms Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 MedRhythms Main Business Overview
11.3.5 MedRhythms Latest Developments
11.4 Curelator
11.4.1 Curelator Company Information
11.4.2 Curelator Digital Therapeutics for Nervous System Diseases Product Offered
11.4.3 Curelator Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Curelator Main Business Overview
11.4.5 Curelator Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Digital Therapeutics for Nervous System Diseases Product Offered
11.5.3 Sanofi Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 GYENNO SCIENCE
11.6.1 GYENNO SCIENCE Company Information
11.6.2 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Product Offered
11.6.3 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GYENNO SCIENCE Main Business Overview
11.6.5 GYENNO SCIENCE Latest Developments
11.7 Cognito Therapeutics
11.7.1 Cognito Therapeutics Company Information
11.7.2 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Product Offered
11.7.3 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cognito Therapeutics Main Business Overview
11.7.5 Cognito Therapeutics Latest Developments
11.8 Nanjing Vishee Medical Technology Co.,Ltd.
11.8.1 Nanjing Vishee Medical Technology Co.,Ltd. Company Information
11.8.2 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
11.8.3 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nanjing Vishee Medical Technology Co.,Ltd. Main Business Overview
11.8.5 Nanjing Vishee Medical Technology Co.,Ltd. Latest Developments
11.9 Glecan
11.9.1 Glecan Company Information
11.9.2 Glecan Digital Therapeutics for Nervous System Diseases Product Offered
11.9.3 Glecan Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Glecan Main Business Overview
11.9.5 Glecan Latest Developments
11.10 Xinkangyx
11.10.1 Xinkangyx Company Information
11.10.2 Xinkangyx Digital Therapeutics for Nervous System Diseases Product Offered
11.10.3 Xinkangyx Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Xinkangyx Main Business Overview
11.10.5 Xinkangyx Latest Developments
11.11 WonderLab
11.11.1 WonderLab Company Information
11.11.2 WonderLab Digital Therapeutics for Nervous System Diseases Product Offered
11.11.3 WonderLab Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 WonderLab Main Business Overview
11.11.5 WonderLab Latest Developments
11.12 BestCovered, Ltd.
11.12.1 BestCovered, Ltd. Company Information
11.12.2 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
11.12.3 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BestCovered, Ltd. Main Business Overview
11.12.5 BestCovered, Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Digital Therapeutics for Nervous System Diseases Market Size (2021-2032)
2.1.2 Digital Therapeutics for Nervous System Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Digital Therapeutics for Nervous System Diseases by Country/Region (2021, 2025 & 2032)
2.2 Digital Therapeutics for Nervous System Diseases Segment by Type
2.2.1 Prevention
2.2.2 Management
2.2.3 Treatment
2.2.4 Digital Therapeutics for Nervous System Diseases Market Size by Type
2.2.4.1 Digital Therapeutics for Nervous System Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
2.3 Digital Therapeutics for Nervous System Diseases Segment by Application
2.3.1 Epilepsy
2.3.2 Parkinson's Disease
2.3.3 Alzheimer's Disease
2.3.4 Other
2.3.5 Digital Therapeutics for Nervous System Diseases Market Size by Application
2.3.5.1 Digital Therapeutics for Nervous System Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
3 DIGITAL THERAPEUTICS FOR NERVOUS SYSTEM DISEASES MARKET SIZE BY PLAYER
3.1 Digital Therapeutics for Nervous System Diseases Market Size Market Share by Player
3.1.1 Global Digital Therapeutics for Nervous System Diseases Revenue by Player (2021-2026)
3.1.2 Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Digital Therapeutics for Nervous System Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIGITAL THERAPEUTICS FOR NERVOUS SYSTEM DISEASES BY REGION
4.1 Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026)
4.2 Global Digital Therapeutics for Nervous System Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
4.4 APAC Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
4.5 Europe Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026)
5.2 Americas Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
5.3 Americas Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026)
6.2 APAC Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
6.3 APAC Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026)
7.2 Europe Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
7.3 Europe Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Digital Therapeutics for Nervous System Diseases by Region (2021-2026)
8.2 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIGITAL THERAPEUTICS FOR NERVOUS SYSTEM DISEASES MARKET FORECAST
10.1 Global Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.1.1 Global Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.1.2 Americas Digital Therapeutics for Nervous System Diseases Forecast
10.1.3 APAC Digital Therapeutics for Nervous System Diseases Forecast
10.1.4 Europe Digital Therapeutics for Nervous System Diseases Forecast
10.1.5 Middle East & Africa Digital Therapeutics for Nervous System Diseases Forecast
10.2 Americas Digital Therapeutics for Nervous System Diseases Forecast by Country (2027-2032)
10.2.1 United States Market Digital Therapeutics for Nervous System Diseases Forecast
10.2.2 Canada Market Digital Therapeutics for Nervous System Diseases Forecast
10.2.3 Mexico Market Digital Therapeutics for Nervous System Diseases Forecast
10.2.4 Brazil Market Digital Therapeutics for Nervous System Diseases Forecast
10.3 APAC Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.3.1 China Digital Therapeutics for Nervous System Diseases Market Forecast
10.3.2 Japan Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.3 Korea Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.4 Southeast Asia Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.5 India Market Digital Therapeutics for Nervous System Diseases Forecast
10.3.6 Australia Market Digital Therapeutics for Nervous System Diseases Forecast
10.4 Europe Digital Therapeutics for Nervous System Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.2 France Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.3 UK Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.4 Italy Market Digital Therapeutics for Nervous System Diseases Forecast
10.4.5 Russia Market Digital Therapeutics for Nervous System Diseases Forecast
10.5 Middle East & Africa Digital Therapeutics for Nervous System Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market Digital Therapeutics for Nervous System Diseases Forecast
10.5.2 South Africa Market Digital Therapeutics for Nervous System Diseases Forecast
10.5.3 Israel Market Digital Therapeutics for Nervous System Diseases Forecast
10.5.4 Turkey Market Digital Therapeutics for Nervous System Diseases Forecast
10.6 Global Digital Therapeutics for Nervous System Diseases Forecast by Type (2027-2032)
10.7 Global Digital Therapeutics for Nervous System Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Digital Therapeutics for Nervous System Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 Zoecare
11.1.1 Zoecare Company Information
11.1.2 Zoecare Digital Therapeutics for Nervous System Diseases Product Offered
11.1.3 Zoecare Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Zoecare Main Business Overview
11.1.5 Zoecare Latest Developments
11.2 66nao
11.2.1 66nao Company Information
11.2.2 66nao Digital Therapeutics for Nervous System Diseases Product Offered
11.2.3 66nao Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 66nao Main Business Overview
11.2.5 66nao Latest Developments
11.3 MedRhythms
11.3.1 MedRhythms Company Information
11.3.2 MedRhythms Digital Therapeutics for Nervous System Diseases Product Offered
11.3.3 MedRhythms Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 MedRhythms Main Business Overview
11.3.5 MedRhythms Latest Developments
11.4 Curelator
11.4.1 Curelator Company Information
11.4.2 Curelator Digital Therapeutics for Nervous System Diseases Product Offered
11.4.3 Curelator Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Curelator Main Business Overview
11.4.5 Curelator Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Digital Therapeutics for Nervous System Diseases Product Offered
11.5.3 Sanofi Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 GYENNO SCIENCE
11.6.1 GYENNO SCIENCE Company Information
11.6.2 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Product Offered
11.6.3 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GYENNO SCIENCE Main Business Overview
11.6.5 GYENNO SCIENCE Latest Developments
11.7 Cognito Therapeutics
11.7.1 Cognito Therapeutics Company Information
11.7.2 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Product Offered
11.7.3 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cognito Therapeutics Main Business Overview
11.7.5 Cognito Therapeutics Latest Developments
11.8 Nanjing Vishee Medical Technology Co.,Ltd.
11.8.1 Nanjing Vishee Medical Technology Co.,Ltd. Company Information
11.8.2 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
11.8.3 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nanjing Vishee Medical Technology Co.,Ltd. Main Business Overview
11.8.5 Nanjing Vishee Medical Technology Co.,Ltd. Latest Developments
11.9 Glecan
11.9.1 Glecan Company Information
11.9.2 Glecan Digital Therapeutics for Nervous System Diseases Product Offered
11.9.3 Glecan Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Glecan Main Business Overview
11.9.5 Glecan Latest Developments
11.10 Xinkangyx
11.10.1 Xinkangyx Company Information
11.10.2 Xinkangyx Digital Therapeutics for Nervous System Diseases Product Offered
11.10.3 Xinkangyx Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Xinkangyx Main Business Overview
11.10.5 Xinkangyx Latest Developments
11.11 WonderLab
11.11.1 WonderLab Company Information
11.11.2 WonderLab Digital Therapeutics for Nervous System Diseases Product Offered
11.11.3 WonderLab Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 WonderLab Main Business Overview
11.11.5 WonderLab Latest Developments
11.12 BestCovered, Ltd.
11.12.1 BestCovered, Ltd. Company Information
11.12.2 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
11.12.3 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BestCovered, Ltd. Main Business Overview
11.12.5 BestCovered, Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Digital Therapeutics for Nervous System Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Digital Therapeutics for Nervous System Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prevention
Table 4. Major Players of Management
Table 5. Major Players of Treatment
Table 6. Digital Therapeutics for Nervous System Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Table 9. Digital Therapeutics for Nervous System Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global Digital Therapeutics for Nervous System Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Player (2021-2026)
Table 14. Digital Therapeutics for Nervous System Diseases Key Players Head office and Products Offered
Table 15. Digital Therapeutics for Nervous System Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global Digital Therapeutics for Nervous System Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Digital Therapeutics for Nervous System Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Digital Therapeutics for Nervous System Diseases
Table 40. Key Market Challenges & Risks of Digital Therapeutics for Nervous System Diseases
Table 41. Key Industry Trends of Digital Therapeutics for Nervous System Diseases
Table 42. Global Digital Therapeutics for Nervous System Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Digital Therapeutics for Nervous System Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Digital Therapeutics for Nervous System Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Zoecare Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 47. Zoecare Digital Therapeutics for Nervous System Diseases Product Offered
Table 48. Zoecare Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Zoecare Main Business
Table 50. Zoecare Latest Developments
Table 51. 66nao Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 52. 66nao Digital Therapeutics for Nervous System Diseases Product Offered
Table 53. 66nao Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. 66nao Main Business
Table 55. 66nao Latest Developments
Table 56. MedRhythms Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 57. MedRhythms Digital Therapeutics for Nervous System Diseases Product Offered
Table 58. MedRhythms Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. MedRhythms Main Business
Table 60. MedRhythms Latest Developments
Table 61. Curelator Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 62. Curelator Digital Therapeutics for Nervous System Diseases Product Offered
Table 63. Curelator Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Curelator Main Business
Table 65. Curelator Latest Developments
Table 66. Sanofi Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 67. Sanofi Digital Therapeutics for Nervous System Diseases Product Offered
Table 68. Sanofi Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sanofi Main Business
Table 70. Sanofi Latest Developments
Table 71. GYENNO SCIENCE Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 72. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Product Offered
Table 73. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. GYENNO SCIENCE Main Business
Table 75. GYENNO SCIENCE Latest Developments
Table 76. Cognito Therapeutics Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 77. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Product Offered
Table 78. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Cognito Therapeutics Main Business
Table 80. Cognito Therapeutics Latest Developments
Table 81. Nanjing Vishee Medical Technology Co.,Ltd. Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 82. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
Table 83. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Nanjing Vishee Medical Technology Co.,Ltd. Main Business
Table 85. Nanjing Vishee Medical Technology Co.,Ltd. Latest Developments
Table 86. Glecan Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 87. Glecan Digital Therapeutics for Nervous System Diseases Product Offered
Table 88. Glecan Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Glecan Main Business
Table 90. Glecan Latest Developments
Table 91. Xinkangyx Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 92. Xinkangyx Digital Therapeutics for Nervous System Diseases Product Offered
Table 93. Xinkangyx Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Xinkangyx Main Business
Table 95. Xinkangyx Latest Developments
Table 96. WonderLab Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 97. WonderLab Digital Therapeutics for Nervous System Diseases Product Offered
Table 98. WonderLab Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. WonderLab Main Business
Table 100. WonderLab Latest Developments
Table 101. BestCovered, Ltd. Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 102. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
Table 103. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. BestCovered, Ltd. Main Business
Table 105. BestCovered, Ltd. Latest Developments
Table 1. Digital Therapeutics for Nervous System Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Digital Therapeutics for Nervous System Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prevention
Table 4. Major Players of Management
Table 5. Major Players of Treatment
Table 6. Digital Therapeutics for Nervous System Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Table 9. Digital Therapeutics for Nervous System Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global Digital Therapeutics for Nervous System Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Player (2021-2026)
Table 14. Digital Therapeutics for Nervous System Diseases Key Players Head office and Products Offered
Table 15. Digital Therapeutics for Nervous System Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global Digital Therapeutics for Nervous System Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Digital Therapeutics for Nervous System Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Digital Therapeutics for Nervous System Diseases
Table 40. Key Market Challenges & Risks of Digital Therapeutics for Nervous System Diseases
Table 41. Key Industry Trends of Digital Therapeutics for Nervous System Diseases
Table 42. Global Digital Therapeutics for Nervous System Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Digital Therapeutics for Nervous System Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Digital Therapeutics for Nervous System Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Zoecare Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 47. Zoecare Digital Therapeutics for Nervous System Diseases Product Offered
Table 48. Zoecare Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Zoecare Main Business
Table 50. Zoecare Latest Developments
Table 51. 66nao Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 52. 66nao Digital Therapeutics for Nervous System Diseases Product Offered
Table 53. 66nao Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. 66nao Main Business
Table 55. 66nao Latest Developments
Table 56. MedRhythms Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 57. MedRhythms Digital Therapeutics for Nervous System Diseases Product Offered
Table 58. MedRhythms Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. MedRhythms Main Business
Table 60. MedRhythms Latest Developments
Table 61. Curelator Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 62. Curelator Digital Therapeutics for Nervous System Diseases Product Offered
Table 63. Curelator Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Curelator Main Business
Table 65. Curelator Latest Developments
Table 66. Sanofi Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 67. Sanofi Digital Therapeutics for Nervous System Diseases Product Offered
Table 68. Sanofi Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sanofi Main Business
Table 70. Sanofi Latest Developments
Table 71. GYENNO SCIENCE Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 72. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Product Offered
Table 73. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. GYENNO SCIENCE Main Business
Table 75. GYENNO SCIENCE Latest Developments
Table 76. Cognito Therapeutics Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 77. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Product Offered
Table 78. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Cognito Therapeutics Main Business
Table 80. Cognito Therapeutics Latest Developments
Table 81. Nanjing Vishee Medical Technology Co.,Ltd. Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 82. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
Table 83. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Nanjing Vishee Medical Technology Co.,Ltd. Main Business
Table 85. Nanjing Vishee Medical Technology Co.,Ltd. Latest Developments
Table 86. Glecan Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 87. Glecan Digital Therapeutics for Nervous System Diseases Product Offered
Table 88. Glecan Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Glecan Main Business
Table 90. Glecan Latest Developments
Table 91. Xinkangyx Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 92. Xinkangyx Digital Therapeutics for Nervous System Diseases Product Offered
Table 93. Xinkangyx Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Xinkangyx Main Business
Table 95. Xinkangyx Latest Developments
Table 96. WonderLab Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 97. WonderLab Digital Therapeutics for Nervous System Diseases Product Offered
Table 98. WonderLab Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. WonderLab Main Business
Table 100. WonderLab Latest Developments
Table 101. BestCovered, Ltd. Details, Company Type, Digital Therapeutics for Nervous System Diseases Area Served and Its Competitors
Table 102. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Product Offered
Table 103. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. BestCovered, Ltd. Main Business
Table 105. BestCovered, Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Digital Therapeutics for Nervous System Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Digital Therapeutics for Nervous System Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Digital Therapeutics for Nervous System Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Digital Therapeutics for Nervous System Diseases Sales Market Share by Country/Region (2025)
Figure 8. Digital Therapeutics for Nervous System Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type in 2025
Figure 10. Digital Therapeutics for Nervous System Diseases in Epilepsy
Figure 11. Global Digital Therapeutics for Nervous System Diseases Market: Epilepsy (2021-2026) & ($ millions)
Figure 12. Digital Therapeutics for Nervous System Diseases in Parkinson's Disease
Figure 13. Global Digital Therapeutics for Nervous System Diseases Market: Parkinson's Disease (2021-2026) & ($ millions)
Figure 14. Digital Therapeutics for Nervous System Diseases in Alzheimer's Disease
Figure 15. Global Digital Therapeutics for Nervous System Diseases Market: Alzheimer's Disease (2021-2026) & ($ millions)
Figure 16. Digital Therapeutics for Nervous System Diseases in Other
Figure 17. Global Digital Therapeutics for Nervous System Diseases Market: Other (2021-2026) & ($ millions)
Figure 18. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application in 2025
Figure 19. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Player in 2025
Figure 20. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Figure 21. Americas Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 22. APAC Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 23. Europe Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 25. Americas Digital Therapeutics for Nervous System Diseases Value Market Share by Country in 2025
Figure 26. United States Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region in 2025
Figure 31. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Figure 32. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Figure 33. China Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. India Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Country in 2025
Figure 40. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Figure 41. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Figure 42. Germany Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. France Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 56. APAC Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 57. Europe Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 59. United States Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 60. Canada Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 61. Mexico Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 62. Brazil Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 63. China Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 64. Japan Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 65. Korea Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 67. India Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 68. Australia Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 69. Germany Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 70. France Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 71. UK Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 72. Italy Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 73. Russia Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 74. Egypt Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 75. South Africa Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 76. Israel Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 77. Turkey Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 78. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 1. Digital Therapeutics for Nervous System Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Digital Therapeutics for Nervous System Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Digital Therapeutics for Nervous System Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Digital Therapeutics for Nervous System Diseases Sales Market Share by Country/Region (2025)
Figure 8. Digital Therapeutics for Nervous System Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type in 2025
Figure 10. Digital Therapeutics for Nervous System Diseases in Epilepsy
Figure 11. Global Digital Therapeutics for Nervous System Diseases Market: Epilepsy (2021-2026) & ($ millions)
Figure 12. Digital Therapeutics for Nervous System Diseases in Parkinson's Disease
Figure 13. Global Digital Therapeutics for Nervous System Diseases Market: Parkinson's Disease (2021-2026) & ($ millions)
Figure 14. Digital Therapeutics for Nervous System Diseases in Alzheimer's Disease
Figure 15. Global Digital Therapeutics for Nervous System Diseases Market: Alzheimer's Disease (2021-2026) & ($ millions)
Figure 16. Digital Therapeutics for Nervous System Diseases in Other
Figure 17. Global Digital Therapeutics for Nervous System Diseases Market: Other (2021-2026) & ($ millions)
Figure 18. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application in 2025
Figure 19. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Player in 2025
Figure 20. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Figure 21. Americas Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 22. APAC Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 23. Europe Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size 2021-2026 ($ millions)
Figure 25. Americas Digital Therapeutics for Nervous System Diseases Value Market Share by Country in 2025
Figure 26. United States Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region in 2025
Figure 31. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Figure 32. APAC Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Figure 33. China Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. India Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Country in 2025
Figure 40. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Figure 41. Europe Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Figure 42. Germany Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. France Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Digital Therapeutics for Nervous System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 56. APAC Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 57. Europe Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 59. United States Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 60. Canada Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 61. Mexico Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 62. Brazil Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 63. China Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 64. Japan Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 65. Korea Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 67. India Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 68. Australia Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 69. Germany Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 70. France Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 71. UK Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 72. Italy Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 73. Russia Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 74. Egypt Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 75. South Africa Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 76. Israel Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 77. Turkey Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
Figure 78. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Digital Therapeutics for Nervous System Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Digital Therapeutics for Nervous System Diseases Market Size 2027-2032 ($ millions)
